Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
25th November 2013
Oligodendrogenesis After Cerebral Ischaemia and Traumatic Brain Injury
Stroke and traumatic brain injury (TBI) damage white and grey matter. Loss of oligodendrocytes and their myelin, impairs axonal function.
25th November 2013
Mode of Delivery in Multiple Sclerosis
Multiple sclerosis (MS) is a chronic immune-mediated disorder of the central nervous system, affecting women of childbearing age. Little is known about…
25th November 2013
Neurorehabilitation After Stroke
Recovery from ischaemic stroke is determined in the acute phase by the lesion impact of ischaemia and subsequently, by functional and structural network…
25th November 2013
Current Essentials in Inflammatory Myopathies
Inflammatory myopathies are a heterogeneous group of acquired systemic diseases, which include dermatomyositis (DM), polymyositis (PM), necrotising…
21st November 2013
Fertility Preservation Options for Cancer Patients
Survival rates for cancer patients have increased in the last few years due to improvements achieved in cancer therapies.
1st November 2013
Evidence-Based Treatment Planning in mCRC: The Key to Maximising Outcomes
This Roche sponsored satellite symposium was held as part of the European Cancer Congress 2013, and reviewed the current evidence available on treatment…
1st November 2013
The Future of Chronic Lymphocytic Leukaemia Treatment: Balancing Efficacy, Safety and Cost
A Review of the Mundipharma International Ltd Organised Symposium, at the International Workshop on Chronic Lymphocytic Leukemia (iwCLL), Cologne…
1st November 2013
Extreme Hypofractionated Image-Guided Radiotherapy for Prostate Cancer
An emerging body of data suggests that hypofractionated radiation schedules, where a higher dose per fraction is delivered in a smaller number of…
1st November 2013
Prostate Cancer and Inflammation: The Role of miRNAs
Approximately 15-20% of all human cancers are assumed to be a result of infection and chronic inflammation due to a constant supply of cytokines and…
1st November 2013
Role of Positron Emission Tomography with Fluorodeoxyglucose in Prostate Cancer
Fluorodeoxyglucose positron emission tomography-computed tomography (FDG PET/CT) has undergone explosive growth in clinical applications and has emerged…
←
1
2
3
…
904
905
906
907
908
909
910
911
912
913
→